Stockscreener 앱 받기
7.0081
0.24%
0.0171
전일 마감가:
$6.991
열려 있는:
$6.48
하루 거래량:
1,002
Relative Volume:
0.18
시가총액:
$8.13M
수익:
$186.70K
순이익/손실:
$-7.33M
주가수익비율:
-0.8309
EPS:
-8.4345
순현금흐름:
$-2.00M
1주 성능:
+16.03%
1개월 성능:
+1.86%
6개월 성능:
-17.75%
1년 성능:
-3.80%
1일 변동 폭
$6.48
$6.85
1주일 범위
$5.41
$7.40
52주 변동 폭
$5.41
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Compare ADXN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
6.60 | 8.13M | 186.70K | -7.33M | -2.00M | -8.4345 |
VRTX
Vertex Pharmaceuticals Inc
|
436.04 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
750.04 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.68 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.89 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.52 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr 주식(ADXN)의 최신 뉴스
Solidion Technology Inc. (NASDAQ:STI) Sees Significant Growth in Short Interest - Defense World
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8% - Defense World
SPDR SSgA Multi-Asset Real Return ETF (NYSEARCA:RLY) Short Interest Up 142.0% in February - Defense World
Short Interest in Intrum AB (publ) (OTCMKTS:ITJTY) Grows By 140.2% - Defense World
Breakwave Tanker Shipping ETF (NYSEARCA:BWET) Short Interest Update - Defense World
Addex Therapeutics (NASDAQ:ADXN) Trading 2% Higher – Here’s Why - Defense World
Addex publishes negative allosteric modulators data in Molecular Psychiatry - TipRanks
CGX Energy (CVE:OYL) Shares Up 17.2% – Should You Buy? - Defense World
FedEx Corporation $FDX Shares Purchased by Transcend Capital Advisors LLC - Defense World
Orex Minerals (CVE:REX) Shares Down 22.8% – What’s Next? - Defense World
Paycom Software (NYSE:PAYC) Price Target Lowered to $210.00 at UBS Group - Defense World
Addex Therapeutics (ADXN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Addex Therapeutics earnings call: Progress amidst financial challenges - MSN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - The Globe and Mail
Addex Therapeutics Reports Q3 2025 Financial Results - The Globe and Mail
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings - Investing.com India
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Total debt per share of Addex Therapeutics Ltd Sponsored ADR – MUN:APE1 - TradingView
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 5.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
How geopolitical risks impact Addex Therapeutics Ltd (APE) stockShare Buyback & Consistent Growth Equity Picks - newser.com
[F-3] Addex Therapeutics Ltd. Foreign Issuer Shelf Registration | ADXN SEC FilingForm F-3 - Stock Titan
Why Addex Therapeutics Ltd (APE) stock stays on buy listsJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Grows By 61.0% - Defense World
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Short Interest Down 91.1% in September - Defense World
Revenue per share of Addex Therapeutics Ltd Sponsored ADR – BER:APE1 - TradingView
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - MSN
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics’ (ADXN) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - The Globe and Mail
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Addex Therapeutics Ltd Stock Price Today | NASDAQ: ADXN Live - Investing.com
European Equities See Growth In US ADR Market - Finimize
Addex Therapeutics Ltd_December 31, 2024 - SEC.gov
Aspire Biopharma (ASBP) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2026 - MarketBeat
Barinthus Biotherapeutics plc (BRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - CNN
60 Degrees Pharmaceuticals (SXTP) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
What is the current Price Target and Forecast for Addex Therapeutics (ADXN) - Zacks Investment Research
Most VolatileStock ScreenerNews - Finviz
Ernexa Therapeutics (ERNA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Trading Halts Explained - MarketBeat
Corbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Addex Therapeutics Ltd Adr (ADXN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
자본화:
|
볼륨(24시간):